<?xml version="1.0" encoding="UTF-8" standalone="no"?>

<MINiML
   xmlns="http://www.ncbi.nlm.nih.gov/geo/info/MINiML"
   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
   xsi:schemaLocation="http://www.ncbi.nlm.nih.gov/geo/info/MINiML http://www.ncbi.nlm.nih.gov/geo/info/MINiML.xsd"
   version="0.5.0" >

  <Contributor iid="contrib1">
    <Person><First>FRANCOIS</First><Last>Patrice</Last></Person>
    <Department>Division of Infectious Diseases</Department>
    <Organization>Genomic Research Laboratory</Organization>
    <Address>
      <Line>Rue Gabrielle-Perret-Gentil, 4  </Line>
      <City>Geneva</City>
      <Postal-Code>1211</Postal-Code>
      <Country>Switzerland</Country>
    </Address>
    <Web-Link>www.genomic.ch</Web-Link>
  </Contributor>

  <Contributor iid="contrib2">
    <Person><First>Patrice</First><Last>Francois</Last></Person>
  </Contributor>

  <Contributor iid="contrib3">
    <Person><First>Antoine</First><Last>Huyghe</Last></Person>
  </Contributor>

  <Contributor iid="contrib4">
    <Person><First>Jacques</First><Last>Schrenzel</Last></Person>
  </Contributor>

  <Contributor iid="contrib5">
    <Person><First>Thomas</First><Middle>M</Middle><Last>Menzel</Last></Person>
  </Contributor>

  <Contributor iid="contrib6">
    <Person><First>Maximilian</First><Last>Tischer</Last></Person>
  </Contributor>

  <Contributor iid="contrib7">
    <Person><First>Patrice</First><Last>François</Last></Person>
  </Contributor>

  <Contributor iid="contrib8">
    <Person><First>Joachim</First><Last>Nickel</Last></Person>
  </Contributor>

  <Contributor iid="contrib9">
    <Person><First>Heike</First><Last>Bruhn</Last></Person>
  </Contributor>

  <Contributor iid="contrib10">
    <Person><First>Annette</First><Last>Albrecht</Last></Person>
  </Contributor>

  <Contributor iid="contrib11">
    <Person><First>Leane</First><Last>Lehmann</Last></Person>
  </Contributor>

  <Contributor iid="contrib12">
    <Person><First>Ulrike</First><Last>Holzgrabe</Last></Person>
  </Contributor>

  <Contributor iid="contrib13">
    <Person><First>Knut</First><Last>Ohlsen</Last></Person>
  </Contributor>

  <Database iid="GEO">
    <Name>Gene Expression Omnibus (GEO)</Name>
    <Public-ID>GEO</Public-ID>
    <Organization>NCBI NLM NIH</Organization>
    <Web-Link>http://www.ncbi.nlm.nih.gov/geo</Web-Link>
    <Email>geo@ncbi.nlm.nih.gov</Email>
  </Database>

  <Platform iid="GPL7137">
    <Status database="GEO">
      <Submission-Date>2008-08-05</Submission-Date>
      <Release-Date>2008-11-07</Release-Date>
      <Last-Update-Date>2011-08-11</Last-Update-Date>
    </Status>
    <Title>Agilent-017903 Staphylococcus aureus V5 Bis 15K (basic)</Title>
    <Accession database="GEO">GPL7137</Accession>
    <Technology>in situ oligonucleotide</Technology>
    <Distribution>custom-commercial</Distribution>
    <Organism taxid="1280">Staphylococcus aureus</Organism>
    <Organism taxid="93061">Staphylococcus aureus subsp. aureus NCTC 8325</Organism>
    <Organism taxid="93062">Staphylococcus aureus subsp. aureus COL</Organism>
    <Organism taxid="158878">Staphylococcus aureus subsp. aureus Mu50</Organism>
    <Organism taxid="158879">Staphylococcus aureus subsp. aureus N315</Organism>
    <Organism taxid="196620">Staphylococcus aureus subsp. aureus MW2</Organism>
    <Organism taxid="282458">Staphylococcus aureus subsp. aureus MRSA252</Organism>
    <Organism taxid="282459">Staphylococcus aureus subsp. aureus MSSA476</Organism>
    <Organism taxid="367830">Staphylococcus aureus subsp. aureus USA300</Organism>
    <Manufacturer>Agilent</Manufacturer>
    <Manufacture-Protocol>
Sure Print Technology-In situ synthesis
    </Manufacture-Protocol>
    <Support>glass</Support>
    <Coating>unknown</Coating>
    <Description>
60-mers oligonucleotide probes, in-situ synthesis
    </Description>
    <Contributor-Ref ref="contrib2" position="1" />
    <Contributor-Ref ref="contrib3" position="2" />
    <Contributor-Ref ref="contrib4" position="3" />
    <Contact-Ref ref="contrib1" />
    <Data-Table>
      <Column position="1">
        <Name>ID</Name>
      </Column>
      <Column position="2">
        <Name>ORF_LIST</Name>
        <Description>Locus tag  </Description>
        <Link-Prefix>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&amp;DB=gene&amp;cmd=search&amp;term=</Link-Prefix>
        <Link-Delimiter>,</Link-Delimiter>
      </Column>
      <Column position="3">
        <Name>Staphylococcus aureus [N315]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus N315 (NC_002745)</Description>
      </Column>
      <Column position="4">
        <Name>Staphylococcus aureus [COL]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus COL (NC_002951)</Description>
      </Column>
      <Column position="5">
        <Name>Staphylococcus aureus [MRSA252]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus MRSA252 (NC_002952)</Description>
      </Column>
      <Column position="6">
        <Name>Staphylococcus aureus [MSSA476]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus MSSA476 (NC_002953)</Description>
      </Column>
      <Column position="7">
        <Name>Staphylococcus aureus [Mu50]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus Mu50 (NC_002758)</Description>
      </Column>
      <Column position="8">
        <Name>Staphylococcus aureus [MW2]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus MW2 (NC_003923)</Description>
      </Column>
      <Column position="9">
        <Name>Staphylococcus aureus [NCTC8325]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus NCTC8325 (NC_007795)</Description>
      </Column>
      <Column position="10">
        <Name>Staphylococcus aureus plasmid [pCOL]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus plasmid pCOL (NC_006629)</Description>
      </Column>
      <Column position="11">
        <Name>Staphylococcus aureus plasmid [pMu50]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus plasmid pMu50 (NC_002774)</Description>
      </Column>
      <Column position="12">
        <Name>Staphylococcus aureus plasmid [pN315]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus plasmid pN315 (NC_003140)</Description>
      </Column>
      <Column position="13">
        <Name>Staphylococcus aureus plasmid [pSAS]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus plasmid pSAS (NC_005951)</Description>
      </Column>
      <Column position="14">
        <Name>Staphylococcus aureus plasmid [pUSA01]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus plasmid pUSA01 (NC_007790)</Description>
      </Column>
      <Column position="15">
        <Name>Staphylococcus aureus plasmid [pUSA02]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus plasmid pUSA02 (NC_007791)</Description>
      </Column>
      <Column position="16">
        <Name>Staphylococcus aureus plasmid [pUSA03]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus plasmid pUSA03 (NC_007792)</Description>
      </Column>
      <Column position="17">
        <Name>Staphylococcus aureus [USA300]</Name>
        <Description>ORF Annotation for genome Staphylococcus aureus USA300 (NC_007793)</Description>
      </Column>
    <External-Data rows="6608">
GPL7137-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Platform>

  <Sample iid="GSM569073">
    <Status database="GEO">
      <Submission-Date>2010-07-22</Submission-Date>
      <Release-Date>2011-01-04</Release-Date>
      <Last-Update-Date>2011-01-04</Last-Update-Date>
    </Status>
    <Title>WT strain untreated versus WT strain treated for 60 minutes with MT02-replicate 1</Title>
    <Accession database="GEO">GSM569073</Accession>
    <Type>RNA</Type>
    <Channel-Count>2</Channel-Count>
    <Channel position="1">
      <Source>S. aureus HG001 w/o MT02, 60 min</Source>
      <Organism taxid="1280">Staphylococcus aureus</Organism>
      <Characteristics tag="strain">
HG001
      </Characteristics>
      <Characteristics tag="agent">
none
      </Characteristics>
      <Growth-Protocol>
mid-log phase at an optical density at 600 nm of 0.6 to 0.8 in Muller-Hinton
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNAprotectTM Bacteria Reagent (Qiagen, Hilden, Germany) and immediately incubated on ice. After centrifugation for 10 min at 6.000 x g and 4°C, the supernatant was discarded and the pellet resuspended in 1 ml RLT-buffer (Qiagen) supplemented with 1 % (vol/vol) β-mercaptoethanol. Cells were disrupted in Lysing Matrix E (MP Biomedicals) using a FastPrep®-24 (MP Biomedicals, Solon, OH, USA), followed by cooling on ice for 2 min. After brief centrifugation, the supernatant was purified using RNeasy®Mini Kit. Final treatment with DNase for 1 h at 37°C and again purified with RNeasy®Mini Kit.
      </Extract-Protocol>
      <Label>cyanine 3</Label>
      <Label-Protocol>
Incorporation during reverse transcription
      </Label-Protocol>
    </Channel>
    <Channel position="2">
      <Source>S. aureus HG001 with MT02, 60 min</Source>
      <Organism taxid="1280">Staphylococcus aureus</Organism>
      <Characteristics tag="strain">
HG001
      </Characteristics>
      <Characteristics tag="agent">
MT02
      </Characteristics>
      <Treatment-Protocol>
Exposition to MT02 for 60 minutes
      </Treatment-Protocol>
      <Growth-Protocol>
mid-log phase at an optical density at 600 nm of 0.6 to 0.8 in Muller-Hinton
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNAprotectTM Bacteria Reagent (Qiagen, Hilden, Germany) and immediately incubated on ice. After centrifugation for 10 min at 6.000 x g and 4°C, the supernatant was discarded and the pellet resuspended in 1 ml RLT-buffer (Qiagen) supplemented with 1 % (vol/vol) β-mercaptoethanol. Cells were disrupted in Lysing Matrix E (MP Biomedicals) using a FastPrep®-24 (MP Biomedicals, Solon, OH, USA), followed by cooling on ice for 2 min. After brief centrifugation, the supernatant was purified using RNeasy®Mini Kit. Final treatment with DNase for 1 h at 37°C and again purified with RNeasy®Mini Kit.
      </Extract-Protocol>
      <Label>cyanine 5</Label>
      <Label-Protocol>
Incorporation during reverse transcription
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
A mixture of RNA from WT and mutant strain was diluted in 50 µl Agilent hybridization buffer, and hybridized at a temperature of 60°C for 17 hours in a dedicated hybridization oven
    </Hybridization-Protocol>
    <Scan-Protocol>
100% PMT using Agilent scanner
    </Scan-Protocol>
    <Description>
S. aureus HG001 exposed or not exposed for 60 min to antimicrobial compound MT02
    </Description>
    <Data-Processing>
Local background-subtracted signals were corrected for unequal dye incorporation or unequal load of labelled product. The algorithm consisted of a rank consistency filter and a curve fit using the GeneSpring 7 default LOWESS (locally weighted linear regression) method.
    </Data-Processing>
    <Platform-Ref ref="GPL7137" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM569nnn/GSM569073/GSM569073.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized log10 ratio (cy5/cy3)</Description>
      </Column>
    <External-Data rows="6608">
GSM569073-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Sample iid="GSM569074">
    <Status database="GEO">
      <Submission-Date>2010-07-22</Submission-Date>
      <Release-Date>2011-01-04</Release-Date>
      <Last-Update-Date>2011-01-04</Last-Update-Date>
    </Status>
    <Title>WT strain untreated versus WT strain treated for 60 minutes with MT02-replicate 2</Title>
    <Accession database="GEO">GSM569074</Accession>
    <Type>RNA</Type>
    <Channel-Count>2</Channel-Count>
    <Channel position="1">
      <Source>S. aureus HG001 w/o MT02, 60 min</Source>
      <Organism taxid="1280">Staphylococcus aureus</Organism>
      <Characteristics tag="strain">
HG001
      </Characteristics>
      <Characteristics tag="agent">
none
      </Characteristics>
      <Growth-Protocol>
mid-log phase at an optical density at 600 nm of 0.6 to 0.8 in Muller-Hinton
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNAprotectTM Bacteria Reagent (Qiagen, Hilden, Germany) and immediately incubated on ice. After centrifugation for 10 min at 6.000 x g and 4°C, the supernatant was discarded and the pellet resuspended in 1 ml RLT-buffer (Qiagen) supplemented with 1 % (vol/vol) β-mercaptoethanol. Cells were disrupted in Lysing Matrix E (MP Biomedicals) using a FastPrep®-24 (MP Biomedicals, Solon, OH, USA), followed by cooling on ice for 2 min. After brief centrifugation, the supernatant was purified using RNeasy®Mini Kit. Final treatment with DNase for 1 h at 37°C and again purified with RNeasy®Mini Kit.
      </Extract-Protocol>
      <Label>cyanine 3</Label>
      <Label-Protocol>
Incorporation during reverse transcription
      </Label-Protocol>
    </Channel>
    <Channel position="2">
      <Source>S. aureus HG001 with MT02, 60 min</Source>
      <Organism taxid="1280">Staphylococcus aureus</Organism>
      <Characteristics tag="strain">
HG001
      </Characteristics>
      <Characteristics tag="agent">
MT02
      </Characteristics>
      <Treatment-Protocol>
Exposition to MT02 for 60 minutes
      </Treatment-Protocol>
      <Growth-Protocol>
mid-log phase at an optical density at 600 nm of 0.6 to 0.8 in Muller-Hinton
      </Growth-Protocol>
      <Molecule>total RNA</Molecule>
      <Extract-Protocol>
RNAprotectTM Bacteria Reagent (Qiagen, Hilden, Germany) and immediately incubated on ice. After centrifugation for 10 min at 6.000 x g and 4°C, the supernatant was discarded and the pellet resuspended in 1 ml RLT-buffer (Qiagen) supplemented with 1 % (vol/vol) β-mercaptoethanol. Cells were disrupted in Lysing Matrix E (MP Biomedicals) using a FastPrep®-24 (MP Biomedicals, Solon, OH, USA), followed by cooling on ice for 2 min. After brief centrifugation, the supernatant was purified using RNeasy®Mini Kit. Final treatment with DNase for 1 h at 37°C and again purified with RNeasy®Mini Kit.
      </Extract-Protocol>
      <Label>cyanine 5</Label>
      <Label-Protocol>
Incorporation during reverse transcription
      </Label-Protocol>
    </Channel>
    <Hybridization-Protocol>
A mixture of RNA from WT and mutant strain was diluted in 50 µl Agilent hybridization buffer, and hybridized at a temperature of 60°C for 17 hours in a dedicated hybridization oven
    </Hybridization-Protocol>
    <Scan-Protocol>
100% PMT using Agilent scanner
    </Scan-Protocol>
    <Description>
S. aureus HG001 exposed or not exposed for 60 min to antimicrobial compound MT02
    </Description>
    <Data-Processing>
Local background-subtracted signals were corrected for unequal dye incorporation or unequal load of labelled product. The algorithm consisted of a rank consistency filter and a curve fit using the GeneSpring 7 default LOWESS (locally weighted linear regression) method.
    </Data-Processing>
    <Platform-Ref ref="GPL7137" />
    <Contact-Ref ref="contrib1" />
    <Supplementary-Data type="TXT">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM569nnn/GSM569074/GSM569074.txt.gz
    </Supplementary-Data>
    <Data-Table>
      <Column position="1">
        <Name>ID_REF</Name>
      </Column>
      <Column position="2">
        <Name>VALUE</Name>
        <Description>Normalized log10 ratio (cy5/cy3)</Description>
      </Column>
    <External-Data rows="6608">
GSM569074-tbl-1.txt
    </External-Data>
    </Data-Table>
  </Sample>

  <Series iid="GSE23077">
    <Status database="GEO">
      <Submission-Date>2010-07-22</Submission-Date>
      <Release-Date>2011-01-04</Release-Date>
      <Last-Update-Date>2012-03-22</Last-Update-Date>
    </Status>
    <Title>Mode of action studies of the novel bisquaternary bisnaphthalimide MT02 against Staphylococcus aureus</Title>
    <Accession database="GEO">GSE23077</Accession>
    <Pubmed-ID>20937782</Pubmed-ID>
    <Summary>
Screening of various bisquaternary bisnaphthalimides against a variety of human pathogens revealed one compound, designated MT02, with strong inhibitory effects against gram-positive bacteria. The minimal inhibitory concentrations ranged from 0.31 µg/ml against community-acquired methicillin resistant Staphylococcus aureus (MRSA) strain USA300 to 20 µg/ml against Streptococcus pneumonia. DNA-microarray studies generated a transcriptional signature characterized by a strong increase of genes involved in DNA-metabolism, DNA-replication, SOS-response and transport of positively charged compounds. Radioactive whole cell labeling experiments indicated a strong impact of MT02 on bacterial DNA-replication. Furthermore, surface plasmon resonance and gel retardation experiments demonstrated direct binding of MT02 to DNA in a concentration dependent, reversible and sequence-unspecific manner. The data presented suggest that the bisquaternary bisnaphthalimide MT02 exerts anti-gram-positive activity by binding to DNA and thereby prohibiting appropriate DNA-replication.
    </Summary>
    <Overall-Design>
WT strain exposed to MT02 for 60 minutes in rich medium
    </Overall-Design>
    <Type>Expression profiling by array</Type>
    <Contributor-Ref ref="contrib5" position="1" />
    <Contributor-Ref ref="contrib6" position="2" />
    <Contributor-Ref ref="contrib7" position="3" />
    <Contributor-Ref ref="contrib8" position="4" />
    <Contributor-Ref ref="contrib4" position="5" />
    <Contributor-Ref ref="contrib9" position="6" />
    <Contributor-Ref ref="contrib10" position="7" />
    <Contributor-Ref ref="contrib11" position="8" />
    <Contributor-Ref ref="contrib12" position="9" />
    <Contributor-Ref ref="contrib13" position="10" />
    <Contact-Ref ref="contrib1" />
    <Sample-Ref ref="GSM569073" />
    <Sample-Ref ref="GSM569074" />
    <Supplementary-Data type="PDF">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/GSE23077/GSE23077_Direct_Label_RNA.pdf.gz
    </Supplementary-Data>
    <Supplementary-Data type="TAR">
ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/series/GSE23077/GSE23077_RAW.tar
    </Supplementary-Data>
    <Relation type="BioProject" target="http://www.ncbi.nlm.nih.gov/bioproject/131687" />
  </Series>

</MINiML>
